MML Investors Services
IBB icon

MML Investors Services’s iShares Biotechnology ETF IBB Stock Holding History

MML Investors Services’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.3M Sell
85,623
-13,344
-13% -$2.29M 0.03% 467
2026
Q1 		$16.7M Sell
98,967
-15,716
-14% -$2.69M 0.05% 381
2025
Q4 		$19.4M Buy
114,683
+48,289
+73% +$7.84M 0.05% 366
2025
Q3 		$9.59M Sell
66,394
-961
-1% -$131K 0.03% 564
2025
Q2 		$8.52M Buy
67,355
+2,302
+4% +$283K 0.02% 577
2025
Q1 		$8.32M Buy
65,053
+81
+0.1% +$11K 0.03% 546
2024
Q4 		$8.59M Buy
64,972
+71
+0.1% +$9.98K 0.03% 494
2024
Q3 		$9.45M Sell
64,901
-1,511
-2% -$219K 0.03% 444
2024
Q2 		$9.12M Sell
66,412
-4,597
-6% -$614K 0.04% 420
2024
Q1 		$9.74M Buy
71,009
+2,425
+4% +$331K 0.04% 421
2023
Q4 		$9.32M Sell
68,584
-13,284
-16% -$1.62M 0.04% 396
2023
Q3 		$10M Sell
81,868
-3,932
-5% -$500K 0.06% 328
2023
Q2 		$10.9M Buy
85,800
+1,790
+2% +$233K 0.06% 310
2023
Q1 		$10.9M Sell
84,010
-9,118
-10% -$1.19M 0.08% 264
2022
Q4 		$12.2M Buy
93,128
+3,828
+4% +$495K 0.08% 265
2022
Q3 		$10.4M Buy
89,300
+5,387
+6% +$669K 0.08% 256
2022
Q2 		$9.87M Sell
83,913
-1,057
-1% -$125K 0.08% 262
2022
Q1 		$11.1M Buy
84,970
+6,395
+8% +$833K 0.08% 255
2021
Q4 		$12M Buy
78,575
+3,087
+4% +$478K 0.09% 242
2021
Q3 		$12.2M Buy
75,488
+1,953
+3% +$329K 0.1% 230
2021
Q2 		$12M Buy
73,535
+5,910
+9% +$910K 0.1% 221
2021
Q1 		$10.2M Sell
67,625
-25,678
-28% -$4.08M 0.1% 232
2020
Q4 		$14.1M Sell
93,303
-27,442
-23% -$3.92M 0.15% 153
2020
Q3 		$16.4M Buy
120,745
+9,240
+8% +$1.25M 0.2% 116
2020
Q2 		$15.2M Buy
111,505
+59,830
+116% +$7.63M 0.2% 113
2020
Q1 		$5.57M Sell
51,675
-9,121
-15% -$1.05M 0.1% 218
2019
Q4 		$7.33M Buy
60,796
+15,849
+35% +$1.77M 0.1% 212
2019
Q3 		$4.47M Sell
44,947
-24,207
-35% -$2.53M 0.07% 258
2019
Q2 		$7.54M Sell
69,154
-7,977
-10% -$848K 0.11% 204
2019
Q1 		$8.62M Sell
77,131
-4,548
-6% -$499K 0.13% 178
2018
Q4 		$7.88M Sell
81,679
-1,714
-2% -$182K 0.14% 176
2018
Q3 		$10.2M Buy
83,393
+26,971
+48% +$3.18M 0.17% 143
2018
Q2 		$6.2M Buy
56,422
+831
+1% +$88.9K 0.14% 167
2018
Q1 		$5.93M Sell
55,591
-1,564
-3% -$173K 0.13% 171
2017
Q4 		$6.1M Sell
57,155
-43,645
-43% -$4.67M 0.12% 167
2017
Q3 		$11.2M Buy
100,800
+5,982
+6% +$639K 0.23% 102
2017
Q2 		$9.8M Buy
+94,818
New +$9.34M 0.19% 113
2016
Q1 		– Sell
-3,030
Closed -$342K – 39
2015
Q4 		$342K Hold
3,030
– – 0.32% 36
2015
Q3 		$306K Buy
3,030
+39
+1% +$4.68K 0.31% 36
2015
Q2 		$368K Buy
+2,991
New +$358K 0.38% 38

Other funds holding IBB

Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
WA
WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
AFG
Albion Financial Group Salt Lake City, Utah $1.73B AUM 20.99% 1-Year Est. Return

MML Investors Services's IBB Position: Q2 2026 in Review

MML Investors Services reduced its iShares Biotechnology ETF (IBB) stake by 13% in Q2 2026, selling an estimated $2.29M and leaving 85,623 shares worth $16.3M. The position accounts for 0.03% of the portfolio, ranked #467.

MML Investors Services first reported a position in IBB in Q2 2015 and has held it in 40 quarters since. The position peaked at $19.4M in Q4 2025. 601 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • MML Investors Services held 85,623 shares of iShares Biotechnology ETF worth $16.3M as of Q2 2026.
  • MML Investors Services sold 13,344 iShares Biotechnology ETF shares in Q2 2026, an estimated $2.29M.
  • iShares Biotechnology ETF made up 0.03% of MML Investors Services's portfolio in Q2 2026, its #467 holding.
  • MML Investors Services first reported a position in iShares Biotechnology ETF in Q2 2015 and has held it in 40 quarters since.
  • MML Investors Services's iShares Biotechnology ETF position peaked at $19.4M in Q4 2025.
  • 601 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.